Clinical trial

Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism

NCT00463346

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Acamprosate Normalized identity: acamprosateView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-09-01

PhasePHASE3

Conditions

Alcohol Dependenceverified · MONDO: alcohol dependence

Schizophreniaverified · MONDO: schizophrenia

Interventions

AcamprosateDRUG · verified · RxNorm: acamprosate

PlaceboDRUG

Sponsors & collaborators

Yale Universitylead sponsor

Forest Laboratoriescollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00463346 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.